Abstract:The present study identified differences in POMC promoter methylation in the peripheral blood of patients with schizophrenia, suggesting that epigenetic variations in POMC may be associated with schizophrenia. These results enrich our understanding of the role of the HPA axis stress response system in the development and progression of schizophrenia. Schizophrenia is a chronic mental disorder that affects millions of people and is believed to be caused by both environmental and genetic factors. Despite extensive research, the exact mechanisms underlying schizophrenia are still unclear. Studies have shown that numerous psychiatric disorders are associated with methylation of the POMC gene, which encodes adrenocorticotropic hormone, a critical player in the hypothalamic–pituitary–adrenal axis. However, the association between DNA methylation in POMC patients and schizophrenia remains unclear. In this study, we evaluated three fragments of the POMC promoter region, including 51 CpG sites, in the peripheral blood of schizophrenia patients and healthy controls. The POMC protein level was measured via enzyme‐linked immunosorbent assay (ELISA). The schizophrenia group exhibited significantly greater levels of methylation of the POMC gene than those in the control group. The methylation level of the POMC‐2 fragment was significantly greater in the patient group than in the control group. There were 17 significantly hypermethylated CpG sites in the patient group. After stratification by sex, POMC methylation levels were found to be significantly greater in male schizophrenia patients than in healthy controls; the methylation levels of POMC‐2 fragments were greater in the male patient group; nine CpG sites were significantly hypermethylated in the male patient group; and only one CpG site was significantly hypermethylated in the female patient group. The POMC protein level in patients was significantly lower than that in healthy controls. These findings demonstrate that the DNA methylation of POMC might be associated with the pathophysiology of schizophrenia. Overall, studying the correlation between POMC methylation and schizophrenia may contribute to the diagnosis and evaluation of neuropsychiatric disorders.

Associations of DNA methylation of HPA axis-related genes and neuroendocrine abnormalities in panic disorder

DNA Methylation of IL-4 Gene and the Association with Childhood Trauma in Panic Disorder

Integrated genome-wide methylation and expression analyses provide predictors of diagnosis and early response to antidepressant in panic disorder

Association study of the BDNF promoter methylation status with panic disorder

Correlation between alterations in neuroendocrine axes and clinical manifestations of panic disorder

Increased Methylation of Glucocorticoid Receptor Gene Promoter 1F in Peripheral Blood of Patients with Generalized Anxiety Disorder

Hypothalamus volume and DNA methylation of stress axis genes in major depressive disorder: A CAN-BIND study report

Epigenetic Signatures of Social Anxiety, Panic Disorders and Stress Experiences: Insights from Genome-wide DNA Methylation Risk Scores

Effects of antidepressant on FKBP51 mRNA expression and neuroendocrine hormones in patients with panic disorder

An analysis of POMC gene methylation and expression in patients with schizophrenia

Increased methylation at an unexplored glucocorticoid responsive element within exon 1D of NR3C1 gene is related to anxious-depressive disorders and decreased hippocampal connectivity

DNA Methylation of Genes Involved in the HPA Axis in Presence of Suicide Behavior: A Systematic Review

Genome-Wide Dna Methylation Analysis in Obsessive-Compulsive Disorder Patients

Association of mineralocorticoid receptor gene (NR3C2) hypermethylation in adult males with aggressive behavior

Association between methylation of the glucocorticoid receptor gene, childhood maltreatment, and clinical severity in borderline personality disorder

Blood endocannabinoid levels in patients with panic disorder

Epigenome-wide DNA methylation analysis of whole blood cells derived from patients with GAD and OCD in the Chinese Han population

Pilot Study of Genome-Wide DNA Methylation and Gene Expression for Treatment Response to Escitalopram in Panic Disorder.

Association analysis of the polymorphisms of dopamine-β-hydroxylase and norepinephrine transporter genes with panic disorder

A control study of gonadal hormone level in female patients with panic disorder

Role of NR3C1 and SLC6A4 methylation in the HPA axis regulation in burnout